Is CBD Legal in Tennessee? Tennessee Cannabis, Hemp, and CBD Laws (2026)

Compliant hemp-derived CBD is available in Tennessee, but a CBD label does not make every formulation legal. THC content, cannabinoid manufacturing, product type and the seller’s authorization all matter. Tennessee has tightened its hemp market, and separate federal changes are scheduled later in 2026.

The distinction between THC-free CBD and a full-spectrum product is especially important. A product containing CBD alongside detectable THC can fall within the regulated hemp-derived cannabinoid product system. Our overview of conditional CBD laws explains why state-specific requirements matter.

Is CBD Legal in Tennessee?

The Tennessee Alcoholic Beverage Commission’s guidance distinguishes products with non-detectable THC, which do not require its hemp license, from otherwise compliant products containing THC up to the state’s 0.3% total-THC limit, which are regulated. Products above that limit are prohibited in the ordinary hemp market. These categories do not override food, drug or other applicable laws.

Consequently, a THC-free CBD topical and a full-spectrum CBD oil need not have the same retail requirements. “Non-intoxicating” marketing is not itself an exemption. Synthetic cannabinoids and THCp are prohibited; the presence of CBD does not make an otherwise prohibited mixture lawful.

How Tennessee Measures THC

The 2018 Farm Bill distinguished hemp from marijuana using a 0.3% delta-9 THC dry-weight threshold, while retaining federal authority over finished products. It did not approve every CBD food, supplement or medicine.

Tennessee’s enacted 2025 overhaul also addresses total theoretical THC: delta-9 THC plus 0.877 times THCA. A laboratory report showing low delta-9 alone can therefore miss a disqualifying amount of THCA. CBD is not counted as THC, but a CBD product’s other constituents still matter.

Who Regulates Tennessee’s Hemp Market?

Hemp-derived cannabinoid product oversight transferred to TABC on January 1, 2026. The Department of Agriculture retained cultivation oversight. Its legacy product licenses continued under the earlier framework through June 30; businesses selling regulated products beyond that date needed TABC authorization.

TABC reported more than 1,300 businesses qualified for the new license by July 2. The transition is now an operating licensing system, rather than a future proposal.

The supplier, wholesaler and retailer tiers have separate requirements. Annual license fees are $2,500, $5,000 and $1,000 respectively; application fees are additional. Wholesalers must demonstrate access to at least $750,000. Retail sales near schools face a 1,000-foot restriction, with an exception for documented qualifying operations predating December 31, 2023. Sellers should consult the current license lists and application guides for their business category.

July 2026 Product Limits and Taxes

The end of the legacy-license period brought existing stores under the new requirements. High-THCA products that exceed 0.3% total THC cannot be sold as compliant hemp. This is more precise than saying every trace of THCA is banned. Synthetic cannabinoids and THCp are separately prohibited regardless of dose.

For covered ingestible products, the serving limit is 15 mg of regulated hemp-derived cannabinoids. The non-beverage package rule uses 20 servings or 300 mg in aggregate; cartridges and plant material have separate limits. Smokeless pouches are limited to 6 mg each and 15 per container. These are statutory cannabinoid limits, not recommended doses or a universal 15 mg cap on CBD itself.

The Department of Revenue administers brand registration and wholesale taxes. Rates depend on form: the general cannabinoid-based rate is two cents per milligram, with separate plant-material and liquid provisions. Do not calculate this tax from CBD milligrams alone.

An additional change is already effective: Public Chapter 1127 added a 10% tax on the wholesale cost of liquid inhalable cartridge products from July 1, 2026. This supplements the existing framework. Our coverage of Tennessee’s finalized hemp rules provides background on the transition.

Federal Rules Can Affect Full-Spectrum CBD

Public Law 119-37 narrows the federal hemp definition, including a finished-product threshold of 0.4 mg per container of combined THC, THCA and specified similar-effect cannabinoids. That is a container threshold, not a serving allowance or a CBD-dose limit. Full-spectrum CBD can be affected despite meeting a percentage-based THC limit.

Section 2019 of the September extension delays most changes until December 11, 2026. Exclusions for cannabinoids the plant cannot naturally produce remain scheduled for November 12. Most other provisions, including the container threshold and the exclusion for naturally occurring cannabinoids manufactured outside the plant, follow in December.

State retail compliance does not exempt a product from federal law. Nor does guidance about Tennessee’s cultivation program establish that all retail CBD is unaffected. Formulations need review against both sets of requirements.

Separately, the FDA’s food and drug rules continue to apply. CBD cannot lawfully be marketed as a dietary supplement or added to food introduced into interstate commerce. Passing a state hemp test does not resolve those restrictions.

Tennessee’s Limited Medical-Oil Exception

Tennessee has no comprehensive medical-marijuana dispensary program. Its 2021 law expanded a narrow exception for CBD oil containing less than 0.9% THC. The threshold is strictly less than 0.9%, not an inclusive maximum.

The expanded provision covers Alzheimer’s disease, ALS, specified cancer circumstances, inflammatory bowel disease including Crohn’s disease and ulcerative colitis, epilepsy or seizures, multiple sclerosis, Parkinson’s disease, HIV/AIDS and sickle cell disease. It requires compliant manufacturer labeling and a valid practitioner attestation identifying the condition and insufficient response to conventional treatment. The letter lasts no more than six months. The earlier seizure-related exception has its own documentation requirements.

This limited possession exception does not establish Tennessee dispensaries, authorize home cultivation or permit general adult use. Federal scheduling changes do not create a Tennessee retail marijuana program either. Patients should distinguish the medical-oil exception from ordinary hemp sales and from an FDA-approved prescription medicine.

Do you need a prescription for CBD in Tennessee?

A prescription is not required for otherwise lawful retail hemp CBD in Tennessee. Hemp-derived CBD products sold in stores and online are consumer goods, not prescription medicines, so a doctor cannot “prescribe” them in the formal sense — at most a clinician may suggest or recommend trying one. The separate low-THC medical oil program is the exception: it requires certification from a Tennessee physician confirming a qualifying condition.

Only one CBD product has cleared the U.S. Food and Drug Administration. Epidiolex is the only FDA-approved drug made from CBD, prescribed for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex in patients one year and older. It was developed by GW Pharmaceuticals, which Jazz Pharmaceuticals (JAZZ ) acquired in 2021. Outside of Epidiolex, the FDA has not approved CBD as a drug, dietary supplement, or food additive, and it treats therapeutic disease claims on CBD products as a violation. If you are considering CBD for a health reason, it is worth raising it with your doctor, especially if you take other medications.

Buying CBD in Tennessee

For regulated hemp-derived cannabinoid products, buyers must be at least 21 and transactions must occur face to face at a licensed retail location. Direct-to-consumer shipping is prohibited for these products. THC-free CBD outside TABC’s hemp licensing category is a different case, but other product and commerce rules still apply. Do not assume every product advertised online as CBD can lawfully ship to Tennessee.

Check the specific batch’s laboratory report for total THC, including THCA, and relevant contaminants. Match the report to the package’s batch number, review the ingredients and manufacturing information, and confirm the seller’s authorization where required. A certificate of analysis reports what was tested; it does not by itself prove lawful manufacture, medical effectiveness or full regulatory compliance.

For a full-spectrum oil, verify its actual THC content rather than relying on a non-intoxicating claim. For an isolate product, confirm that the formulation and manufacturing meet the applicable rules. Neither a familiar brand nor a checkout page guarantees legality.